239 filings
Page 3 of 12
NT 10-K
ymkm 8pk99pni73l4
31 Mar 22
Notice of late annual filing
10:54am
8-K
koft7kvwffmeryn8ux6
9 Mar 22
AXIM Biotech Launches For Research Use Only Sales for its COVID-19 Neutralizing Antibody Test
4:37pm
8-K
djjn97gg
16 Feb 22
Entry into a Material Definitive Agreement
4:33pm
8-K
cgwms k7xbb9nzrw
12 Jan 22
Departure of Directors or Certain Officers
12:00am
8-K
4b1ff30h9d48n93kizd8
7 Jan 22
Departure of Directors or Certain Officers
4:21pm
NT 10-Q
0npl 24yw2
15 Nov 21
Notice of late quarterly filing
1:28pm
NT 10-Q
4ktiqnv yrykk
16 Aug 21
Notice of late quarterly filing
12:00am
8-K
vdqhp85
4 Aug 21
AXIM® Biotechnologies to Acquire Technology Including Two FDA-Cleared 510(k)’s for Diagnostic Testing of Dry Eye Disease
12:00am
EFFECT
v5wow67 dqxgw2te
23 Jun 21
Notice of effectiveness
12:15am
CORRESP
yi0rza0yjkxq634c89qb
21 Jun 21
Correspondence with SEC
12:00am
S-1/A
9crnqsik act
9 Jun 21
IPO registration (amended)
5:08pm
UPLOAD
aou24umm yfgga5knrl
19 May 21
Letter from SEC
12:00am
NT 10-Q
irg1i
14 May 21
Notice of late quarterly filing
5:26pm
S-1
o3nky ta6kx5
14 May 21
IPO registration
5:17pm